Cancer
patients
treated with
systemic adjuvant chemotherapy
deteriorations
cognition
chemotherapeutic agent
5-fluorouracil
5-FU
crosses
blood-brain barrier
brain function
anti mitotic drug
reduce
cell proliferation
neurogenic regions
adult
brain
hippocampal
dependent
neurogenesis
cognition
enhanced
SSRI
antidepressant
Fluoxetine
investigation
behavioural
effects of
chronic
treatment
5-FU
weeks
Fluoxetine
combination
5-FU
tested
adult
Lister hooded rats
Behavioural effects
emotional response test
CER
animals
treated with
5-FU
reduction
freezing time
controls
group
animals
hippocampal
spatial working memory test
object location recognition test
OLR
Animals
treated
5-FU
deficits
OLR
task
co administration
Fluoxetine
improved
performance
5-FU chemotherapy
reduction
proliferating cells
sub granular zone
dentate gyrus
compared
controls
reduction
Fluoxetine
co administered
5-FU
Fluoxetine
proliferating cell number
behaviour
findings
5-FU
negatively
cell proliferation
hippocampal
dependent
working memory
deficits
simultaneous
administration
antidepressant
Fluoxetine
